Wednesday, November 6, Miami Neuro Nursing Symposium - Eighth Annual (6 Cat. 1)

• Describe experiences shared by stroke survivors that identify strategies they found useful to cope with the diagnosis. 

• Recognize the importance of a pre-hospital stroke evaluation to ensure that patients receive timely diagnosis and treatment.

• Describe the imaging modalities used to diagnose acute stroke.

• Recognize the utility and indications of imaging results in acute stroke.

• Determine the precise etiology of a stroke in order to minimize complications and prevent recurrence. 

• Describe the use of antithrombotic treatments for patients in the first days after acute ischemic stroke onset. 

• Recognize the importance of evaluating patients who present to the clinic with neurologic symptoms that may be consistent with stroke.

• Recognize the clinical features and diagnosis of convulsive status epilepticus in adults.

• Explain how causes, prognoses and treatments of status epilepticus differ in adults, and describe optimal evaluation and treatment requirements. 

• Demonstrate how to prepare for sustained success in certified stroke centers.

• Recognize best practices for maintaining high-reliability stroke centers.

• Explain the evaluation and initial management of injuries to the cervical spinal column in adults, including the appropriate use of imaging studies. 

• Recognize the clinical presentation of movement disorders: Parkinson’s disease, essential tremor and dystonia. 

• Demonstrate the need for timely medical management of Parkinson’s disease and determine what medications to avoid.

• Demonstrate proper guidance on how to manage the family and patient regarding postoperative expectations.

Thursday, November 7, Miami Neuro Symposium - Ninth Annual (Day 1) (6 Cat. 1)

• Recognize triage patients who are possible candidates for IV TPA or endovascular treatment as stroke alerts.

• Describe proper patient selection of patients for IV TPA.

• Describe proper selection of patients for endovascular treatment.

• Explain common pitfalls for patient selection.

• Recognize and comply with Baptist Health’s stroke policy regarding acute stroke treatments.

• Examine the proper imaging workup in patients presenting with symptoms and signs of acute ischemic stroke.

• Recognize the advantages and disadvantages of CTA.

• Explain the pitfalls of CT perfusion.

• Analyze randomized trials, real-life registries and new devices in acute stroke thrombectomy.

• Recognize how antiplatelet therapy reduces the incidence of stroke in patients at high risk for atherosclerosis and in those with known symptomatic cerebrovascular disease.

• Identify several “rare” causes of stroke that most neurologists will encounter and describe the management of these conditions.

• Analyze current information on the efficacy and safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases and summarize key aspects of best practice.

• Assess recent data relevant to new technologies and emerging treatment strategies in cerebral arteriovenous malformations.

• Examine recent research advances in intracerebral hematoma and describe current management strategies.

• Illustrate a contemporary, evidence-based outline of the perioperative critical care management of patients with subarachnoid hemorrhage.

• Describe the evaluation and management of hematologic disorders associated with stroke. 

• Recognize the evaluation and management of heparin-induced-thrombocytopenia. 

• Identify common risk factors for PRES, RCVS and vasculitis. 

• Recognize typical and atypical presentation of PRES, RCVS and vasculitis.

Friday, November 8, Miami Neuro Symposium (Day 2) (6 Cat. 1)

• Explain multiple modalities of treatments that are of increasing interest in epilepsy.

• Describe recent behavioral clinical trials in epilepsy, including cognitive behavioral therapy, mindfulness, progressive muscle relaxation and self-management. 

• Explain why new therapies such as calcitonin gene-related peptide (CGRP) antagonists and neuromodulation devices are needed for the treatment of migraine.

• Describe CGRP antagonist treatments for patients with migraine.

• Examine neuromodulation treatments for patients with migraine.

• Review the American Headache Society’s position statement on integrating new migraine treatments into clinical practice.

• Describe various types of status epilepticus and explain appropriate treatment approaches. 

• Distinguish primary from secondary headaches.

• Examine an algorithmic approach to classifying and diagnosing primary headache disorders.

• Analyze diagnostic criteria for chronic migraine and other types of primary chronic daily headache.

• Recognize risk factors for migraine chronification. 

• Explain how to formulate a multidisciplinary treatment plan for patients with migraine.

• Examine the medical literature about the use of cannabis as a potential treatment for adults with essential tremor and appropriately disseminate information to patients regarding its use.

• Analyze current, clinical, state-of-the-art functional neurosurgery in the treatment of Parkinson's disease, tremor and dystonia.

• Demonstrate the importance of continuous objective measures in the optimal selection of deep brain stimulation candidates with Parkinson’s disease.

• Explain the recent technical advances in deep brain stimulation. 

• Examine the epidemiology, diagnosis and differential diagnosis of neuromuscular disorders.  

• Evaluate the clinical features of ALS.

• Accurately diagnose and manage the early cognitive manifestations of dementias.

• Recognize clinical, diagnostic and pathological aspects of specific dementia syndromes and describe the treatment, risk factors and prevention.

• Describe the diagnosis and differential diagnosis of multiple sclerosis and examine treatment options for acute exacerbations.  

• Recognize anti-seizure effects of cannabis and its use in treatment of Lennox Gastaut and Dravet syndromes.

• Critically examine the expanding range of evidence on the efficacy of these compounds in the management of different seizure types and epilepsy syndromes. 

• Examine the medical literature about the use of cannabis in other neurological conditions and appropriately disseminate information to patients regarding its use.